These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22532282)

  • 1. [Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 2: Practical aspects of application].
    von Bernus L; Högger P; Pfaar O; Klimek L
    HNO; 2012 Aug; 60(8):700-6. PubMed ID: 22532282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 1: Pathophysiology, molecular basis].
    Klimek L; Högger P; Pfaar O
    HNO; 2012 Jul; 60(7):611-7. PubMed ID: 22532281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical practice guideline: Allergic rhinitis.
    Seidman MD; Gurgel RK; Lin SY; Schwartz SR; Baroody FM; Bonner JR; Dawson DE; Dykewicz MS; Hackell JM; Han JK; Ishman SL; Krouse HJ; Malekzadeh S; Mims JW; Omole FS; Reddy WD; Wallace DV; Walsh SA; Warren BE; Wilson MN; Nnacheta LC;
    Otolaryngol Head Neck Surg; 2015 Feb; 152(1 Suppl):S1-43. PubMed ID: 25644617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of intranasal corticosteroids in the management of pediatric allergic rhinitis.
    Kaari J
    Clin Pediatr (Phila); 2006 Oct; 45(8):697-704. PubMed ID: 16968954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.
    Di Lorenzo G; Pacor ML; Pellitteri ME; Morici G; Di Gregoli A; Lo Bianco C; Ditta V; Martinelli N; Candore G; Mansueto P; Rini GB; Corrocher R; Caruso C
    Clin Exp Allergy; 2004 Feb; 34(2):259-67. PubMed ID: 14987306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of nasal congestion: the role of intranasal corticosteroids.
    Benninger M
    Postgrad Med; 2009 Jan; 121(1):122-31. PubMed ID: 19179820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily budesonide aqueous nasal spray for allergic rhinitis: a review.
    Stanaland BE
    Clin Ther; 2004 Apr; 26(4):473-92. PubMed ID: 15189745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis.
    Yáñez A; Rodrigo GJ
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):479-84. PubMed ID: 12452206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis.
    Okano M
    Clin Exp Immunol; 2009 Nov; 158(2):164-73. PubMed ID: 19737138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluticasone propionate: topical or systemic effects?
    Howland WC
    Clin Exp Allergy; 1996 May; 26 Suppl 3():18-22. PubMed ID: 8735854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids.
    Karaki M; Akiyama K; Mori N
    Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed genomic and acute nongenomic action of glucocorticosteroids in seasonal allergic rhinitis.
    Tillmann HC; Stuck BA; Feuring M; Rossol-Haseroth K; Tran BM; Lösel R; Schmidt BM; Hörmann K; Wehling M; Schultz A
    Eur J Clin Invest; 2004 Jan; 34(1):67-73. PubMed ID: 14984440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.
    Salib RJ; Howarth PH
    Drug Saf; 2003; 26(12):863-93. PubMed ID: 12959630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid.
    Ahlström-Emanuelsson C; Persson CG; Svensson C; Andersson M; Hosszu Z; Akerlund A; Greiff L
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):159-65. PubMed ID: 12197572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergic rhinitis: meaningful and less meaningful combination treatments including reminiscences.
    Szelenyi I
    Pharmazie; 2014 Jun; 69(6):414-6. PubMed ID: 24974572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of treatments for allergic rhinitis in children.
    Baena-Cagnani CE
    Drug Saf; 2004; 27(12):883-98. PubMed ID: 15366976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of nasal glucocorticoid combined with loratadine or montelukast on allergic rhinitis].
    Jia MH; Chen XY; Zhang Y; Liao ZS
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):369-373. PubMed ID: 29871264
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of allergic rhinitis: focus on intranasal agents.
    Dushay ME; Johnson CE
    Pharmacotherapy; 1989; 9(6):338-50. PubMed ID: 2575739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis.
    Krug N; Gupta A; Badorrek P; Koenen R; Mueller M; Pivovarova A; Hilbert J; Wetzel K; Hohlfeld JM; Wood C
    J Allergy Clin Immunol; 2014 Feb; 133(2):414-9. PubMed ID: 24332218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.